TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Aventis Pharma Deutschland GmbH
Curated by ChEMBL
Aventis Pharma Deutschland GmbH
Curated by ChEMBL
Affinity DataIC50: 55nMAssay Description:Concentration required to reduce binding of Kistrin to Vitronectin receptor (alpha V beta 3) by 50%More data for this Ligand-Target Pair